Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats
Open Access
- 8 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (4), 1904-1929
- https://doi.org/10.1021/acs.jmedchem.0c00627
Abstract
The modulation of melatonin signaling in peripheral tissues holds promise for treating metabolic diseases like obesity, diabetes, and nonalcoholic steatohepatitis. Here, several benzimidazole derivatives have been identified as novel agonists of the melatonin receptors MT1 and MT2. The lead compounds 10b, 15a, and 19a demonstrated subnanomolar potency at MT1/MT2 receptors, high oral bioavailability in rodents, peripherally preferred exposure, and excellent selectivity in a broad panel of targets. Two-month oral administration of 10b in high-fat diet rats led to a reduction in body weight gain similar to dapagliflozin with superior results on hepatic steatosis and triglyceride levels. An early toxicological assessment indicated that 10b (also codified as ACH-000143) was devoid of hERG binding, genotoxicity, and behavioral alterations at doses up to 100 mg/kg p.o., supporting further investigation of this compound as a drug candidate.Keywords
Funding Information
- Ach? Laborat?rios Farmac?uticos
This publication has 82 references indexed in Scilit:
- Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndromeLaboratory Investigation, 2013
- Reducing safety-related drug attrition: the use of in vitro pharmacological profilingNature Reviews Drug Discovery, 2012
- Removal of Melatonin Receptor Type 1 Induces Insulin Resistance in the MouseObesity, 2010
- CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expressionJournal of Thrombosis and Haemostasis, 2006
- Melatonin ameliorates nonalcoholic fatty liver induced by high‐fat diet in ratsJournal of Pineal Research, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog β-methyl-6-chloromelatoninLife Sciences, 2004
- Multi-wavelength spectrophotometric determination of acid dissociation constants: a validation studyAnalytica Chimica Acta, 2001
- Pharmacological characterization of human recombinant melatonin mt1 and MT2 receptorsBritish Journal of Pharmacology, 2000
- Regioselective Synthesis of Benzimidazolic Bioisosteres of MelatoninSynthetic Communications, 1994